Professional Development Cafés
Gene and cell therapy is at the forefront of medical innovation, offering groundbreaking treatments for diseases once deemed incurable. As these therapies advance, the role of intellectual property (IP) becomes increasingly vital. IP protection is essential for encouraging innovation, securing investments, and bringing these therapies to market. However, gene and cell therapies' unique and complex nature presents significant IP challenges, including navigating a dynamic regulatory environment, addressing ethical concerns, and managing the global scope of research and development.
This ASGCT Professional Development Cafe will gather experts from law, biotechnology, and the scientific community to discuss these challenges and explore strategies for effective IP management. By fostering collaboration and dialogue, this event aims to equip stakeholders with the tools to navigate the evolving IP landscape, ultimately advancing the field and improving patient outcomes.
Agenda
Moderator: Marta Bozek, PhD, Ospedale San Raffaele, San Raffaele Telethon Institute for Gene Therapy, SR-Tiget
Speaker: Dana J. Vouglitois, JD, CLP, Florida Atlantic University
Ms. Vouglitois will discuss the different types of IP, focusing mostly on patents, and how the protection and commercialization process works.
Learning Objectives
- Identify and address key challenges about patenting, ethical concerns, and regulatory compliance
- Develop effective IP management strategies
- Promote collaboration across disciplines
- Develop skills for navigating the global IP landscape